Beutel, Goodman & CO Ltd. Biogen Inc. Transaction History

Beutel, Goodman & CO Ltd.

$20.3 Billion
Q3 2024

A detailed history of Beutel, Goodman & CO Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Beutel, Goodman & CO Ltd. holds 1,744,154 shares of BIIB stock, worth $255 Million. This represents 1.67% of its overall portfolio holdings.

Number of Shares

1,744,154

Previous 1,747,444 0.19%

Holding current value

$255 Million

Previous $405 Million 16.54%

% of portfolio

1.67%

Previous 2.15%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $622,040 - $779,072	-3,290 Reduced 0.19%	1,744,154 $338 Million
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $34.6 Million - $43 Million	181,659 Added 11.6%	1,747,444 $405 Million
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $121 Million - $153 Million	570,329 Added 57.29%	1,565,785 $338 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $850,293 - $1.02 Million	-3,820 Reduced 0.38%	995,456 $258 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $17,731 - $20,012	-70 Reduced 0.01%	999,276 $257 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $5.95 Million - $6.88 Million	21,620 Added 2.21%	999,346 $285 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $5.86 Million - $6.67 Million	22,830 Added 2.39%	977,726 $272 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $778,777 - $946,231	-3,085 Reduced 0.32%	954,896 $264 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $1.6 Million - $2.2 Million	-8,205 Reduced 0.85%	957,981 $256 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $4.88 Million - $5.8 Million	26,025 Added 2.77%	966,186 $197 Million
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $5.16 Million - $6.5 Million	26,625 Added 2.91%	940,161 $198 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $81.4 Million - $105 Million	363,520 Added 66.09%	913,536 $219 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $118 Million - $153 Million	415,883 Added 310.05%	550,016 $156 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $9.95 Million - $15.9 Million	-38,399 Reduced 22.26%	134,133 $46.4 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $41.9 Million - $49.1 Million	172,532 New	172,532 $48.3 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beutel, Goodman & CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Beutel, Goodman & CO Ltd. with notifications on news.

Account

Beutel, Goodman & CO Ltd. Biogen Inc. Transaction History